Literature DB >> 15759129

Cytomegalovirus infection inhibits the expression of N-methyl-D-aspartate receptors in the developing mouse hippocampus and primary neuronal cultures.

Isao Kosugi1, Hideya Kawasaki, Takashi Tsuchida, Yoshihiro Tsutsui.   

Abstract

Cytomegalovirus (CMV) is the most significant infectious cause of developmental brain disorders in humans. The infection occasionally persists and causes neurological disorders. The N-methyl-D-aspartate (NMDA) subtype of glutamate receptors is essential for the development and plasticity of synapses, but also is involved in neuronal excitotoxicity during viral infection. Here we investigated the effects of murine CMV (MCMV) infection on the expression of NMDA receptors in the hippocampal neurons of neonatal mice and primary neuronal cultures. Viral antigen was mostly found in hippocampal pyramidal neurons from the CA1 to CA3. Image analysis of immunohistochemistry demonstrated that the expression of NMDA receptor subunit 1 (NMDA-R1) protein in CA1 neurons of MCMV-infected brain was reduced to 40% of that in uninfected brain. The signal of in situ hybridization for NMDA-R1 mRNA was also decreased in CA1 neurons of MCMV-infected brain. In primary neuronal cultures, reduction of NMDA-R1 expression in MCMV-infected neurons was also detected by immunocytochemistry and Western blotting. These results suggest that reduction of NMDA receptor expression by MCMV infection may cause a decrease in the susceptibility of the neurons to excitotoxic cell death, and may be related to the establishment of viral persistence and functional disturbances in MCMV-infected neurons.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15759129     DOI: 10.1007/s00401-005-0987-7

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  8 in total

1.  Long-term neurobiological consequences of early postnatal hCMV-infection in former preterms: a functional MRI study.

Authors:  Maik Dorn; Karen Lidzba; Andrea Bevot; Rangmar Goelz; Till-Karsten Hauser; Marko Wilke
Journal:  Hum Brain Mapp       Date:  2013-09-11       Impact factor: 5.038

2.  Early infections of Toxoplasma gondii and the later development of schizophrenia.

Authors:  Preben Bo Mortensen; Bent Nørgaard-Pedersen; Berit L Waltoft; Tina L Sørensen; David Hougaard; Robert H Yolken
Journal:  Schizophr Bull       Date:  2007-02-28       Impact factor: 9.306

Review 3.  Cytomegalovirus and HIV: A Dangerous Pas de Deux.

Authors:  Sara Gianella; Scott Letendre
Journal:  J Infect Dis       Date:  2016-10-01       Impact factor: 5.226

Review 4.  Neuropathogenesis of congenital cytomegalovirus infection: disease mechanisms and prospects for intervention.

Authors:  Maxim C-J Cheeran; James R Lokensgard; Mark R Schleiss
Journal:  Clin Microbiol Rev       Date:  2009-01       Impact factor: 26.132

Review 5.  Toxoplasma gondii and cognitive deficits in schizophrenia: an animal model perspective.

Authors:  Geetha Kannan; Mikhail V Pletnikov
Journal:  Schizophr Bull       Date:  2012-09-01       Impact factor: 9.306

Review 6.  Schizophrenia susceptibility genes directly implicated in the life cycles of pathogens: cytomegalovirus, influenza, herpes simplex, rubella, and Toxoplasma gondii.

Authors:  C J Carter
Journal:  Schizophr Bull       Date:  2008-06-13       Impact factor: 9.306

7.  Prolonged activation of cytomegalovirus early gene e1-promoter exclusively in neurons during infection of the developing cerebrum.

Authors:  Isao Kosugi; Yoshifumi Arai; Satoshi Baba; Hideya Kawasaki; Toshihide Iwashita; Yoshihiro Tsutsui
Journal:  Acta Neuropathol Commun       Date:  2021-03-09       Impact factor: 7.801

8.  Human induced pluripotent stem cell-derived models to investigate human cytomegalovirus infection in neural cells.

Authors:  Leonardo D'Aiuto; Roberto Di Maio; Brianna Heath; Giorgio Raimondi; Jadranka Milosevic; Annie M Watson; Mikhil Bamne; W Tony Parks; Lei Yang; Bo Lin; Toshio Miki; Jocelyn Danielle Mich-Basso; Ravit Arav-Boger; Etienne Sibille; Sarven Sabunciyan; Robert Yolken; Vishwajit Nimgaonkar
Journal:  PLoS One       Date:  2012-11-27       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.